Satish Shanbhag

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

Julie R. Brahmer, Hamzah Abu‐Sbeih, Paolo A. Ascierto et al. · Journal for ImmunoTherapy of Cancer · 2021 · 826 citations · Full text

Pharmacy, Immunology, Oncology +17

Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults

Yvette L. Kasamon, Javier Bolaños‐Meade, Gabrielle T. Prince et al. · Journal of Clinical Oncology · 2015 · 239 citations

Medicine, Hematology, Immunology +17

Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study

Michael S. Khodadoust, Alain H. Rook, Pierluigi Porcu et al. · Journal of Clinical Oncology · 2019 · 229 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020

Neha Mehta–Shah, Stephen M. Ansell, Weiyun Z. Ai et al. · Journal of the National Comprehensive Cancer Network · 2020 · 118 citations · Full text

Medicine, Hematology, Oncology +17

Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors

Harshvardhan Upreti, Jamil Kasmani, Kathryn Dane et al. · Blood · 2019 · 110 citations · Full text

Medicine, Molecular Medicine, Neurology +2